Abstract
Purpose
PIK3CA mutation or overexpression is associated with immunotherapy resistance in multiple cancer types, but is also paradoxically associated with benefit of COX-2 inhibition on patient survival of colorectal cancer (CRC) with mismatch repair deficiency (dMMR). This study examined whether and how PIK3CA status affected COX-2-mediated tumor inflammation and immunotherapy response of dMMR CRC.
Methods
Murine colon cancer cells MC38, CT26, and CT26-Mlh1-KO were used to construct PIK3CA knockdown and overexpression models to mimic dMMR CRC with PIK3CA dysregulation, and xenograft models were used to evaluate how PIK3CA regulate COX-2 expression, CD8+ T cells infiltration, tumor growth, and therapy response to anti-PD-L1 treatment using immunocompetent mice. Western blot was carried out to delineate the signaling pathways in human and mouse cancer cells, and immunohistochemical analysis together with bioinformatics analysis using human patient samples.
Results
PIK3CA upregulates COX-2 expression through MEK/ERK signaling pathway independent of AKT signaling to promote tumor inflammation and immunosuppression. PIK3CA knockdown profoundly reduced CT26 tumor growth in a CD8+ T cell-dependent manner, while PIK3CA overexpression significantly inhibited CD8+ T cells infiltration and promoted tumor growth. Furthermore, MEK or COX-2 inhibition augmented the anti-tumor activity of anti-PD-L1 immunotherapy on dMMR CRC mouse models, accompanied with increased CD8+ T cells infiltration and activated tumor microenvironment.
Conclusion
Our results identified that the PIK3CA hyperactivation in dMMR CRC upregulated COX-2 through MEK signaling, which inhibited CD8+ T cells infiltration and promoted tumor growth, together led to immunotherapy resistance. COX-2 or MEK inhibition may relieve therapy resistance and promote therapy efficacy of anti-PD-1/PD-L1 immunotherapy for treating dMMR CRC with PIK3CA overexpression or activating mutation.
Similar content being viewed by others
Data availability
The data are available from the corresponding authors upon reasonable request.
References
R.L. Siegel, K.D. Miller, H.E. Fuchs, A. Jemal, CA Cancer J. Clinicians 71, 7–33 (2021). https://doi.org/10.3322/caac.21654
G. Jung, E. Hernandez-Illan, L. Moreira, F. Balaguer, A. Goel, Nature reviews. Gastroenterol. Hepatol. 17, 111–130 (2020). https://doi.org/10.1038/s41575-019-0230-y
D. Tougeron, B. Sueur, A. Zaanan, C. de la Fouchardiere, D. Sefrioui, T. Lecomte, T. Aparicio, G. Des Guetz, P. Artru, V. Hautefeuille, R. Coriat, V. Moulin, C. Locher, Y. Touchefeu, C. Lecaille, G. Goujon, A. Ferru, C. Evrard, R. Chautard, L. Gentilhomme, D. Vernerey, J. Taieb, T. Andre, J. Henriques, R. Cohen, O. Association Des Gastro-enterologues, Int. J. Cancer 147, 285–296 (2020). https://doi.org/10.1002/ijc.32879
T. Andre, K.K. Shiu, T.W. Kim, B.V. Jensen, L.H. Jensen, C. Punt, D. Smith, R. Garcia-Carbonero, M. Benavides, P. Gibbs, C. de la Fouchardiere, F. Rivera, E. Elez, J. Bendell, D.T. Le, T. Yoshino, E. Van Cutsem, P. Yang, M.Z.H. Farooqui, P. Marinello, L.A. Diaz Jr., K. Investigators, New Engl. J. Med. 383, 2207–2218 (2020). https://doi.org/10.1056/NEJMoa2017699
D.T. Le, T.W. Kim, E. Van Cutsem, R. Geva, D. Jager, H. Hara, M. Burge, B. O’Neil, P. Kavan, T. Yoshino, R. Guimbaud, H. Taniguchi, E. Elez, S.E. Al-Batran, P.M. Boland, T. Crocenzi, C.E. Atreya, Y. Cui, T. Dai, P. Marinello, L.A. Diaz Jr., T. Andre, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 38, 11–19 (2020). https://doi.org/10.1200/JCO.19.02107
Z.K. Stadler, F. Battaglin, S. Middha, J.F. Hechtman, C. Tran, A. Cercek, R. Yaeger, N.H. Segal, A.M. Varghese, D.L. Reidy-Lagunes, N.E. Kemeny, E.E. Salo-Mullen, A. Ashraf, M.R. Weiser, J. Garcia-Aguilar, M.E. Robson, K. Offit, M.E. Arcila, M.F. Berger, J. Shia, D.B. Solit, L.B. Saltz, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 34, 2141–2147 (2016). https://doi.org/10.1200/JCO.2015.65.1067
D.T. Le, J.N. Durham, K.N. Smith, H. Wang, B.R. Bartlett, L.K. Aulakh, S. Lu, H. Kemberling, C. Wilt, B.S. Luber, F. Wong, N.S. Azad, A.A. Rucki, D. Laheru, R. Donehower, A. Zaheer, G.A. Fisher, T.S. Crocenzi, J.J. Lee, T.F. Greten, A.G. Duffy, K.K. Ciombor, A.D. Eyring, B.H. Lam, A. Joe, S.P. Kang, M. Holdhoff, L. Danilova, L. Cope, C. Meyer, S. Zhou, R.M. Goldberg, D.K. Armstrong, K.M. Bever, A.N. Fader, J. Taube, F. Housseau, D. Spetzler, N. Xiao, D.M. Pardoll, N. Papadopoulos, K.W. Kinzler, J.R. Eshleman, B. Vogelstein, R.A. Anders, L.A. Diaz Jr., Science 357, 409–413 (2017). https://doi.org/10.1126/science.aan6733
I.D. Hiles, M. Otsu, S. Volinia, M.J. Fry, I. Gout, R. Dhand, G. Panayotou, F. Ruiz-Larrea, A. Thompson, N.F. Totty And, et al., Cell 70, 419–429 (1992). https://doi.org/10.1016/0092-8674(92)90166-a
Y. Samuels, Z. Wang, A. Bardelli, N. Silliman, J. Ptak, S. Szabo, H. Yan, A. Gazdar, S.M. Powell, G.J. Riggins, J.K. Willson, S. Markowitz, K.W. Kinzler, B. Vogelstein, V.E. Velculescu, Science 304, 554 (2004). https://doi.org/10.1126/science.1096502
D.A. Fruman, H. Chiu, B.D. Hopkins, S. Bagrodia, L.C. Cantley, R.T. Abraham, Cell 170, 605–635 (2017). https://doi.org/10.1016/j.cell.2017.07.029
Z.B. Mei, C.Y. Duan, C.B. Li, L. Cui, S. Ogino, Ann. Oncol. 27, 1836–1848 (2016). https://doi.org/10.1093/annonc/mdw264
M.L. Chong, M. Loh, B. Thakkar, B. Pang, B. Iacopetta, R. Soong, Int. J. Cancer 134, 1232–1238 (2014). https://doi.org/10.1002/ijc.28444
R.S. Sandler, S. Halabi, J.A. Baron, S. Budinger, E. Paskett, R. Keresztes, N. Petrelli, J.M. Pipas, D.D. Karp, C.L. Loprinzi, G. Steinbach, R. Schilsky, New Engl. J. Med. 348, 883–890 (2003). https://doi.org/10.1056/NEJMoa021633
J. Burn, A.M. Gerdes, F. Macrae, J.P. Mecklin, G. Moeslein, S. Olschwang, D. Eccles, D.G. Evans, E.R. Maher, L. Bertario, M.L. Bisgaard, M.G. Dunlop, J.W. Ho, S.V. Hodgson, A. Lindblom, J. Lubinski, P.J. Morrison, V. Murday, R. Ramesar, L. Side, R.J. Scott, H.J. Thomas, H.F. Vasen, G. Barker, G. Crawford, F. Elliott, M. Movahedi, K. Pylvanainen, J.T. Wijnen, R. Fodde, H.T. Lynch, J.C. Mathers, D.T. Bishop, C. Investigators, Lancet 378, 2081–2087 (2011). https://doi.org/10.1016/S0140-6736(11)61049-0
X. Liao, P. Lochhead, R. Nishihara, T. Morikawa, A. Kuchiba, M. Yamauchi, Y. Imamura, Z.R. Qian, Y. Baba, K. Shima, R. Sun, K. Nosho, J.A. Meyerhardt, E. Giovannucci, C.S. Fuchs, A.T. Chan, S. Ogino, New Engl. J. Med. 367, 1596–1606 (2012). https://doi.org/10.1056/NEJMoa1207756
A.T. Chan, S. Ogino, C.S. Fuchs, JAMA 302, 649–658 (2009). https://doi.org/10.1001/jama.2009.1112
E. Domingo, D.N. Church, O. Sieber, R. Ramamoorthy, Y. Yanagisawa, E. Johnstone, B. Davidson, D.J. Kerr, I.P. Tomlinson, R. Midgley, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 31, 4297–4305 (2013). https://doi.org/10.1200/JCO.2013.50.0322
T. Hamada, Y. Cao, Z.R. Qian, Y. Masugi, J.A. Nowak, J. Yang, M. Song, K. Mima, K. Kosumi, L. Liu, Y. Shi, A. da Silva, M. Gu, W. Li, N. Keum, X. Zhang, K. Wu, J.A. Meyerhardt, E.L. Giovannucci, M. Giannakis, S.J. Rodig, G.J. Freeman, D. Nevo, M. Wang, A.T. Chan, C.S. Fuchs, R. Nishihara, S. Ogino, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 35, 1836–1844 (2017). https://doi.org/10.1200/JCO.2016.70.7547
S. Zelenay, A.G. van der Veen, J.P. Bottcher, K.J. Snelgrove, N. Rogers, S.E. Acton, P. Chakravarty, M.R. Girotti, R. Marais, S.A. Quezada, E. Sahai, C. Reis E Sousa, Cell 162, 1257–1270 (2015). https://doi.org/10.1016/j.cell.2015.08.015
C.R. Bell, V.S. Pelly, A. Moeini, S.C. Chiang, E. Flanagan, C.P. Bromley, C. Clark, C.H. Earnshaw, M.A. Koufaki, E. Bonavita, S. Zelenay, Nat. Commun. 13, 2063 (2022). https://doi.org/10.1038/s41467-022-29606-9
H. Hu, L. Kang, J. Zhang, Z. Wu, H. Wang, M. Huang, P. Lan, X. Wu, C. Wang, W. Cao, J. Hu, Y. Huang, L. Huang, H. Wang, L. Shi, Y. Cai, C. Shen, J. Ling, X. Xie, Y. Cai, X. He, R. Dou, J. Zhou, T. Ma, X. Zhang, S. Luo, W. Deng, L. Ling, H. Liu, Y. Deng, Lancet Gastroenterol. Hepatol. 7, 38–48 (2022). https://doi.org/10.1016/S2468-1253(21)00348-4
J. Li, C. Wu, H. Hu, G. Qin, X. Wu, F. Bai, J. Zhang, Y. Cai, Y. Huang, C. Wang, J. Yang, Y. Luan, Z. Jiang, J. Ling, Z. Wu, Y. Chen, Z. Xie, Y. Deng, Cancer Cell 41, 1152–1169 e1157 (2023). https://doi.org/10.1016/j.ccell.2023.04.011
T.J. Alban, T.A. Chan, Nat. Rev. Clin. Oncol. 18, 323–324 (2021). https://doi.org/10.1038/s41571-021-00498-w
N. Sivaram, P.A. McLaughlin, H.V. Han, O. Petrenko, Y.P. Jiang, L.M. Ballou, K. Pham, C. Liu, A.W. van der Velden, R.Z. Lin, J. Clin. Invest. 129, 3264–3276 (2019). https://doi.org/10.1172/JCI123540
A. Marabelle, D.T. Le, P.A. Ascierto, A.M. Di Giacomo, A. De Jesus-Acosta, J.P. Delord, R. Geva, M. Gottfried, N. Penel, A.R. Hansen, S.A. Piha-Paul, T. Doi, B. Gao, H.C. Chung, J. Lopez-Martin, Y.J. Bang, R.S. Frommer, M. Shah, R. Ghori, A.K. Joe, S.K. Pruitt, L.A. Diaz Jr., J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol. 38, 1–10 (2020). https://doi.org/10.1200/JCO.19.02105
G. Germano, S. Lamba, G. Rospo, L. Barault, A. Magri, F. Maione, M. Russo, G. Crisafulli, A. Bartolini, G. Lerda, G. Siravegna, B. Mussolin, R. Frapolli, M. Montone, F. Morano, F. de Braud, N. Amirouchene-Angelozzi, S. Marsoni, M. D’Incalci, A. Orlandi, E. Giraudo, A. Sartore-Bianchi, S. Siena, F. Pietrantonio, F. Di Nicolantonio, A. Bardelli, Nature 552, 116–120 (2017). https://doi.org/10.1038/nature24673
C. Lu, J. Guan, S. Lu, Q. Jin, B. Rousseau, T. Lu, D. Stephens, H. Zhang, J. Zhu, M. Yang, Z. Ren, Y. Liang, Z. Liu, C. Han, L. Liu, X. Cao, A. Zhang, J. Qiao, K. Batten, M. Chen, D.H. Castrillon, T. Wang, B. Li, L.A. Diaz Jr., G.M. Li, Y.X. Fu, Cancer Cell 39, 96–108 e106 (2021). https://doi.org/10.1016/j.ccell.2020.11.006
C. Mao, Z.Y. Yang, X.F. Hu, Q. Chen, J.L. Tang, Ann. Oncol. 23, 1518–1525 (2012). https://doi.org/10.1093/annonc/mdr464
Q. Wang, Y.L. Shi, K. Zhou, L.L. Wang, Z.X. Yan, Y.L. Liu, L.L. Xu, S.W. Zhao, H.L. Chu, T.T. Shi, Q.H. Ma, J. Bi, Cell Death Dis. 9, 739 (2018). https://doi.org/10.1038/s41419-018-0776-6
Y. Samuels, T. Waldman, Curr. Top. Microbiol. Immunol. 347, 21–41 (2010). https://doi.org/10.1007/82_2010_68
G. Hoxhaj, B.D. Manning, Nature reviews. Cancer 20, 74–88 (2020). https://doi.org/10.1038/s41568-019-0216-7
J. Sai, P. Owens, S.V. Novitskiy, O.E. Hawkins, A.E. Vilgelm, J. Yang, T. Sobolik, N. Lavender, A.C. Johnson, C. McClain, G.D. Ayers, M.C. Kelley, M. Sanders, I.A. Mayer, H.L. Moses, M. Boothby, A. Richmond, Clin. Cancer. Res. 23, 3371–3384 (2017). https://doi.org/10.1158/1078-0432.CCR-16-2142
R. Abu-Eid, R.N. Samara, L. Ozbun, M.Y. Abdalla, J.A. Berzofsky, K.M. Friedman, M. Mkrtichyan, S.N. Khleif, Cancer Immunol. Res. 2, 1080–1089 (2014). https://doi.org/10.1158/2326-6066.CIR-14-0095
M.C. Schmid, C.J. Avraamides, H.C. Dippold, I. Franco, P. Foubert, L.G. Ellies, L.M. Acevedo, J.R. Manglicmot, X. Song, W. Wrasidlo, S.L. Blair, M.H. Ginsberg, D.A. Cheresh, E. Hirsch, S.J. Field, J.A. Varner, Cancer Cell 19, 715–727 (2011). https://doi.org/10.1016/j.ccr.2011.04.016
A.J. Dannenberg, K. Subbaramaiah, Cancer Cell 4, 431–436 (2003). https://doi.org/10.1016/s1535-6108(03)00310-6
K. Uchida, S. Schneider, J.M. Yochim, H. Kuramochi, K. Hayashi, K. Takasaki, D. Yang, K.D. Danenberg, P.V. Danenberg, Clin. Cancer Res. 11, 3363–3368 (2005). https://doi.org/10.1158/1078-0432.CCR-04-1650
K. Kosumi, T. Hamada, S. Zhang, L. Liu, A. da Silva, H. Koh, T.S. Twombly, K. Mima, T. Morikawa, M. Song, J.A. Nowak, R. Nishihara, L.B. Saltz, D. Niedzwiecki, F.S. Ou, T. Zemla, R.J. Mayer, H. Baba, K. Ng, M. Giannakis, X. Zhang, K. Wu, E.L. Giovannucci, A.T. Chan, C.S. Fuchs, J.A. Meyerhardt, S. Ogino, Eur. J. Cancer 111, 82–93 (2019). https://doi.org/10.1016/j.ejca.2019.01.022
S. Yaqub, K. Henjum, M. Mahic, F.L. Jahnsen, E.M. Aandahl, B.A. Bjornbeth, K. Tasken, Cancer Immunol. Immunother. 57, 813–821 (2008). https://doi.org/10.1007/s00262-007-0417-x
E. Ryschich, T. Notzel, U. Hinz, F. Autschbach, J. Ferguson, I. Simon, J. Weitz, B. Frohlich, E. Klar, M.W. Buchler, J. Schmidt, Clin. Cancer Res. 11, 498–504 (2005)
M.F. Krummel, J.P. Allison, J. Exp. Med. 182, 459–465 (1995). https://doi.org/10.1084/jem.182.2.459
C. Sun, R. Mezzadra, T.N. Schumacher, Immunity 48, 434–452 (2018). https://doi.org/10.1016/j.immuni.2018.03.014
M. Ahtiainen, E.V. Wirta, T. Kuopio, T. Seppala, J. Rantala, J.P. Mecklin, J. Bohm, Mod. Pathol. 32, 866–883 (2019). https://doi.org/10.1038/s41379-019-0219-7
P.J.R. Ebert, J. Cheung, Y. Yang, E. McNamara, R. Hong, M. Moskalenko, S.E. Gould, H. Maecker, B.A. Irving, J.M. Kim, M. Belvin, I. Mellman, Immunity 44, 609–621 (2016). https://doi.org/10.1016/j.immuni.2016.01.024
V. Verma, N. Jafarzadeh, S. Boi, S. Kundu, Z. Jiang, Y. Fan, J. Lopez, R. Nandre, P. Zeng, F. Alolaqi, S. Ahmad, P. Gaur, S.T. Barry, V.E. Valge-Archer, P.D. Smith, J. Banchereau, M. Mkrtichyan, B. Youngblood, P.C. Rodriguez, S. Gupta, S.N. Khleif, Nat. Immunol. 22, 53–66 (2021). https://doi.org/10.1038/s41590-020-00818-9
L. Liu, P.A. Mayes, S. Eastman, H. Shi, S. Yadavilli, T. Zhang, J. Yang, L. Seestaller-Wehr, S.Y. Zhang, C. Hopson, L. Tsvetkov, J. Jing, S. Zhang, J. Smothers, A. Hoos, Clin. Cancer Res. 21, 1639–1651 (2015). https://doi.org/10.1158/1078-0432.CCR-14-2339
R.J. Sullivan, O. Hamid, R. Gonzalez, J.R. Infante, M.R. Patel, F.S. Hodi, K.D. Lewis, H.A. Tawbi, G. Hernandez, M.J. Wongchenko, Y. Chang, L. Roberts, M. Ballinger, Y. Yan, E. Cha, P. Hwu, Nature Med. 25, 929–935 (2019). https://doi.org/10.1038/s41591-019-0474-7
A. Ribas, D. Lawrence, V. Atkinson, S. Agarwal, W.H. Miller Jr., M.S. Carlino, R. Fisher, G.V. Long, F.S. Hodi, J. Tsoi, C.S. Grasso, B. Mookerjee, Q. Zhao, R. Ghori, B.H. Moreno, N. Ibrahim, O. Hamid, Nature Med. 25, 936–940 (2019). https://doi.org/10.1038/s41591-019-0476-5
C. Eng, T.W. Kim, J. Bendell, G. Argiles, N.C. Tebbutt, M. Di Bartolomeo, A. Falcone, M. Fakih, M. Kozloff, N.H. Segal, A. Sobrero, Y. Yan, I. Chang, A. Uyei, L. Roberts, F. Ciardiello, I.M. Investigators, Lancet Oncol. 20, 849–861 (2019). https://doi.org/10.1016/S1470-2045(19)30027-0
D.T. Le, J.N. Uram, H. Wang, B.R. Bartlett, H. Kemberling, A.D. Eyring, A.D. Skora, B.S. Luber, N.S. Azad, D. Laheru, B. Biedrzycki, R.C. Donehower, A. Zaheer, G.A. Fisher, T.S. Crocenzi, J.J. Lee, S.M. Duffy, R.M. Goldberg, A. de la Chapelle, M. Koshiji, F. Bhaijee, T. Huebner, R.H. Hruban, L.D. Wood, N. Cuka, D.M. Pardoll, N. Papadopoulos, K.W. Kinzler, S. Zhou, T.C. Cornish, J.M. Taube, R.A. Anders, J.R. Eshleman, B. Vogelstein, L.A. Diaz Jr., New Engl. J. Med. 372, 2509–2520 (2015). https://doi.org/10.1056/NEJMoa1500596
N.J. Llosa, M. Cruise, A. Tam, E.C. Wicks, E.M. Hechenbleikner, J.M. Taube, R.L. Blosser, H. Fan, H. Wang, B.S. Luber, M. Zhang, N. Papadopoulos, K.W. Kinzler, B. Vogelstein, C.L. Sears, R.A. Anders, D.M. Pardoll, F. Housseau, Cancer Discov. 5, 43–51 (2015). https://doi.org/10.1158/2159-8290.CD-14-0863
Z. Gatalica, C. Snyder, T. Maney, A. Ghazalpour, D.A. Holterman, N. Xiao, P. Overberg, I. Rose, G.D. Basu, S. Vranic, H.T. Lynch, D.D. Von Hoff, O. Hamid, Cancer Epidemiol. Biomarkers Prev. 23, 2965–2970 (2014). https://doi.org/10.1158/1055-9965.EPI-14-0654
J. Wang, R. Li, Y. He, Y. Yi, H. Wu, Z. Liang, Mod. Pathol. 33, 2591–2601 (2020). https://doi.org/10.1038/s41379-020-0612-2
W. Li, T. Qiu, L. Dong, F. Zhang, L. Guo, J. Ying, J. Cancer 11, 3827–3833 (2020). https://doi.org/10.7150/jca.37437
Acknowledgements
We thank Dr. Wenjing Xiong of Sun Yat-sen University Cancer Center for technical assistance. This work was supported by grants from the National Natural Science Foundation of China (82102995, 81972692, 82073140, 81902905, 81902491), Tencent Foundation (SYSU-84000-20220420-0001), and Guangdong Basic and Applied Basic Research Foundation (2021A1515012080).
Author information
Authors and Affiliations
Contributions
K.P., X.X. and L.X. conceived and designed the study. K.P. conducted most experiments and wrote the manuscript. Y.L. and S.L. performed some key experiments; Z.W., H.Z., W.H., Y.J. and L.W. performed parts of the experiments. X.X. and L.X. supervised the project and revised the manuscript. All authors read and approved the final manuscript.
Corresponding authors
Ethics declarations
Ethical approval
The study was approved by the Ethics Committee of Sun Yat-Sen University Cancer Center, and all patients had been provided written informed consent for their data and surgical specimens to be used for research purposes. All mice were maintained under Specific Pathogen-Free (SPF) conditions and in accordance with the animal experiment guidelines of Sun Yat-sen University (Guangzhou, China). All animal procedures were approved by the Institutional Animal Care and Use Committee of Sun Yat-sen University (Guangzhou, China).
Competing interests
None declared.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Peng, K., Liu, Y., Liu, S. et al. Targeting MEK/COX-2 axis improve immunotherapy efficacy in dMMR colorectal cancer with PIK3CA overexpression. Cell Oncol. (2024). https://doi.org/10.1007/s13402-024-00916-y
Accepted:
Published:
DOI: https://doi.org/10.1007/s13402-024-00916-y